Elevated neutrophil/lymphocyte ratio in patients with schizophrenia

Psychiatria Danubina

Volumn 26, Issue 3, 2014, Pages 220-225

  Semiz, Murat ^a   Yildirim, Osman ^b   Canan, Fatih ^c   Demir, Suleyman ^d   Hasbek, Ekrem ^e   Tuman, Taha Can ^b   Kayka, Nefise ^b   Tosun, Mehmet ^b  

^a Department of Psychiatry Gaziozmanpasa University School of Medicine   (Turkey)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^c AKDENIZ UNIVERSITY   (Turkey)

^d DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^e Sivas Devlet Hastanesi   (Turkey)

Author keywords

Immunology; Inflammation; Lymphocyte; Neutrophil; Neutrophil lymphocyte ratio; Schizophrenia

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; BLOOD CELL COUNT; BODY MASS; BRIEF PSYCHIATRIC RATING SCALE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHIL LYMPHOCYTE RATIO; SCHIZOPHRENIA; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; THROMBOCYTE COUNT; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE COUNT; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; REFERENCE VALUE; STATISTICS; TURKEY (REPUBLIC);

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS AS TOPIC; TURKEY;

EID: 84907161027     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ayhan SS, Oztürk S, Erdem A, Ozlü MF, Ozyaşar M, Erdem K, et al: Relation of neutrophil/lymphocyte ratio with the presence and severity of coronary artery ectasia. Turk Kardiyol Dern Ars 2013; 41:185-190.
2. Azab B, Jaglall N, Atallah JP, Lamet A, Raja-Surya V, Farah B, et al: Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology 2011; 11:445-452.
3. Dhabhar FS: Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection and Immunopathology. Neuroimmunomodulation 2009; 16:300-317.
4. Erminio T, Bertoni G: Some physiological and biochemical methods for acute and chronic stress evaluation in dairy cows. Ital J Anim Sci 2009; 8:265-286.
5. Fan X, Liu EY, Freudenreich O, Park JH, Liu D, Wang J, et al: Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia. Schizophr Res 2010; 118:211-217.
6. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Clinical Version. American Psychiatric Press, Washington, DC, 1997.
7. Fowler AJ, Agha RA: Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography - the growing versatility of NLR. Atherosclerosis 2013; 228:44-45.
8. Gwak MS, Choi SJ, Kim JA, Ko JS, Kim TH, Lee SM, et al: Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio following gastrectomy in patients with stomach cancer. J Korean Med Sci 2007; 22:104-108.
9. Henneberg A, Riedl B, Dumke HO, Kornhuber HH: T-lymphocyte subpopulations in schizophrenic patients. Eur Arch Psychiatry Neurol Sci 2007; 239:283-284.
10. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150.
11. Kuyumcu ME, Yesil Y, Oztürk ZA, Kizilarslanoʇlu C, Etgül S, Halil M, et al: The evaluation of neutrophillymphocyte ratio in Alzheimer's disease. Dement Geriatr Cogn Disord 2012; 34:69-74.
12. Jubin Z, Bonnie S: Vulnerability: A new view of schizophrenia. J Abnorm Psychol 2012; 86:103-126.
13. Lieberman JA: Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 1999; 46:729-739.
14. Maino K, Gruber R, Riedel M, Seitz N, Schwarz M, Müller N: T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment. Psychiatry Res 2007; 152:173-180.
15. Mazzarello V, Cecchini A, Fenu G, Rassu M, Dessy LA, Lorettu L, et al: Lymphocytes in schizophrenic patients under therapy: serological, morphological and cell subset findings. Ital J Anat Embryol 2004; 109:177-188.
16. Maxeiner HG, Rojewski MT, Schmitt A, Tumani H, Bechter K, Schmitt M: Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders. Brain Behav Immun 2009; 23:134-142.
17. Müller N, Hofschuster E, Ackenheil M, Eckstein R: T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy. Acta Psychiatr Scand 1993; 87:66-71.
18. Müller N, Riedel M, Ackenheil M, Schwarz MJ: The role of immune function in schizophrenia: an overview. Eur. Arch. Psychiatry. Clin Neurosci 1999; 249:62-68.
19. Müller N, Schwarz MJ: Immune System and Schizophrenia. Curr Immunol Rev 2010; 6:213-220.
20. Müller N: The role of anti-inflammatory treatment in psychiatric disorders. Psychiatr Danub 2013; 25:292-298.
21. Naneishvili BR, Zurabashvili ZA: The ultrastructure of formed white blood elements (neutrophils) in schizophrenia. Folia Haematol Int Mag Klin Morphol Blutforsch 1976; 103:160-165.
22. Nikkilä HV, Müller K, Ahokas A, Rimón R, Andersson LC: Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia. Schizophr Res 2001: 49:99-105.
23. Overall JE, Gorham DR: The brief psychiatric rating scale. Pyschol Rep 1962; 10:799-812.
24. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E: Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008; 63:801-808.
25. Puppe B, Tuchscherer M, Tuchscherer A: The effect of housing conditions and social environment immediately after weaning on the agonistic behaviour, neutrophil/lymphocyte ratio, and plasma glucose level in pigs. Livestock Prod Sci 1997; 48:157-164.
26. Rothermundt M, Arolt V, Bayer TA: Review of immunological and immunopathological findings in schizophrenia. Brain Behav Immun 2001; 15:319-339.
27. Rudolf S, Schlenke P, Broocks A, Peters M, Rothermundt M, Arolt V, et al: Search for atypical lymphocytes in schizophrenia. World J Biol Psychiatry 2004; 5:33-37.
28. Schattner A, Cori Y, Hahn T, Sirota P: No evidence for autoimmunity in schizophrenia. J Autoimmun 1996; 9:661-666.
29. Seretis C, Gourgiotis S, Gemenetzis G, Seretis F, Lagoudianakis E, Dimitrakopoulos G: The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study. Am J Surg 2013; 205:691-696.
30. Smith RS, Maes M: The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med Hypotheses 1995; 45:135-141.
31. Sperner-Unterweger B, Whitworth A, Kemmler G, Hilbe W, Thaler J, Weiss G, et al: T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients. Schizophr Res 1999; 38:61-70.
32. Steiner J, Jacobs R, Panteli B, Brauner M, Schiltz K, Bahn S, et al: Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity. Eur Arch Psychiatry Clin Neurosci 2010; 260: 509-518.
33. Szkandera J, Absenger G, Liegl-Atzwanger B, Pichler M, Stotz M, Samonigg H, Glehr M, et al: Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients. Br J Cancer 2013; 108:1677-1683.
34. Weinberger DR, McClure RK: Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry 2002; 59:553-558.
35. Zahorec R.: Ratio of neutrophil to lymphocyte counts - rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102:5-14.
36. Zandi MS, Irani SR, Lang B, Waters P, Jones PB, McKenna P, et al: Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 2011; 258:686-688.